Episode 1: From SF Healthcare Week, Matt interviews Brad Loncar about M&A and China's potential impact on it

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/e7/66/0f/e7660f00-8019-aef4-d34e-9d59466f5274/mza_14263396379458283641.jpg/600x600bb.jpg

Off-Target Effects with Matt Gline

BiotechTV

4 episodes

2 days ago

Matt shares a biotech CEO's perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.

Life Sciences

Science

RSS

All content for Off-Target Effects with Matt Gline is the property of BiotechTV and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Matt shares a biotech CEO's perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43070788/43070788-1739783498247-a9db0b33906ff.jpg

Episode 1: From SF Healthcare Week, Matt interviews Brad Loncar about M&A and China's potential impact on it

Off-Target Effects with Matt Gline

32 minutes 6 seconds

8 months ago

Episode 1: From SF Healthcare Week, Matt interviews Brad Loncar about M&A and China's potential impact on it

For the first episode of the new video podcast, Matt turns the tables on Brad Loncar and interviews him about his experiences and knowledge of investing in China biotech over the years. They discuss the rise of China biotech and how it might or might not be impacting M&A in the sector.